Meridian Investment Counsel’s Invesco S&P SmallCap Health Care ETF PSCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$204K Hold
3,909
– – 0.05% 227
2026
Q2
$205K Buy
+3,909
New +$178K 0.04% 243
2022
Q2
– Sell
-3,909
Closed -$210K – 217
2022
Q1
$210K Hold
3,909
– – 0.07% 195
2021
Q4
$234K Hold
3,909
– – 0.08% 196
2021
Q3
$238K Hold
3,909
– – 0.09% 186
2021
Q2
$252K Hold
3,909
– – 0.09% 176
2021
Q1
$240K Hold
3,909
– – 0.09% 169
2020
Q4
$221K Buy
+3,909
New +$195K 0.09% 169
2020
Q1
– Sell
-4,698
Closed -$202K – 181
2019
Q4
$202K Buy
+4,698
New +$190K 0.1% 173
2018
Q4
– Sell
-4,698
Closed -$220K – 176
2018
Q3
$220K Hold
4,698
– – 0.12% 164
2018
Q2
$201K Buy
+4,698
New +$190K 0.11% 173

Other funds holding PSCH

Meridian Investment Counsel's PSCH Position: Q3 2026 in Review

Meridian Investment Counsel held its Invesco S&P SmallCap Health Care ETF (PSCH) position steady in Q3 2026 at 3,909 shares worth $204K. The position accounts for 0.05% of the portfolio, ranked #227.

Meridian Investment Counsel first reported a position in PSCH in Q2 2018 and has held it in 11 quarters since. The position peaked at $252K in Q2 2021. 9 funds tracked by Wall St. Rank hold PSCH as of Q3 2026.

  • Meridian Investment Counsel held 3,909 shares of Invesco S&P SmallCap Health Care ETF worth $204K as of Q3 2026.
  • Meridian Investment Counsel left its Invesco S&P SmallCap Health Care ETF share count unchanged in Q3 2026.
  • Invesco S&P SmallCap Health Care ETF made up 0.05% of Meridian Investment Counsel's portfolio in Q3 2026, its #227 holding.
  • Meridian Investment Counsel first reported a position in Invesco S&P SmallCap Health Care ETF in Q2 2018 and has held it in 11 quarters since.
  • Meridian Investment Counsel's Invesco S&P SmallCap Health Care ETF position peaked at $252K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Invesco S&P SmallCap Health Care ETF as of Q3 2026.

Based on Meridian Investment Counsel's 13F filing for Q3 2026, filed 14 Oct 2026.